ArticleScientific reports2025
Interaction between gender and age on the methylation levels of KLF14 promoter.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Krüppel-like factor 14 enhances fatty acid oxidation to combat pulmonary fibrosis.Respiratory research · 2026Article
- Genetic variations and functions of KLF14 in gene expression and metabolic disease development.Journal of applied genetics · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigated the relationship between age, sex, and methylation levels of the Krüppel-like factor 14 (KLF14) promoter. Utilizing data from the Taiwan Biobank (TWB), established in 2005, we analyzed a cohort of 1,141 participants. DNA methylation analyses were conducted by Health GeneTech Corp., commissioned by TWB. Methylation levels of the KLF14 promoter were determined by averaging the values of 10 CpG sites: cg09823095, cg25109431, cg21449170, cg05651960, cg18751682, cg08097417, cg07955995, cg22285878, cg21520933, and cg06533629. Participants were divided into four age groups (30-40, 40-50, 50-60, and 60-70 years). Multiple linear regression analyses were performed to assess the impact of age and sex on KLF14 promoter methylation and to evaluate the interaction between these variables. Our findings revealed that men exhibited higher KLF14 promoter methylation levels, with a significant age-dependent increase. Notably, in participants aged over 50, KLF14 methylation levels were substantially higher in men compared to women (β = 0.00336, P = 0.0108 for the 50-60 age group; β = 0.00472, P = 0.0238 for the 60-70 age group). Our study reveals a sex-specific increase in KLF14 promoter methylation among men over 50, with no significant differences observed in individuals younger than 50. This finding suggests that age and sex may play a crucial role in the epigenetic regulation of KLF14.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.